Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2016 Jun 14.

Published in final edited form as: Psychiatry Res. 2016 Jan 14;237:311–315. doi: 10.1016/j.psychres.2016.01.023

Table 3.

The standardized coefficient between symptom measures and substance use characteristics using multiple linear regressions.

	B	Beta	P	R2
BDI				0.108
Ketamine use frequency	1.241	.283	<.001^**
Duration of ketamine dependence	.008	.030	.692
Maximum ketamine dose	.208	.089	.414
Average ketamine dose	−.076	−.070	.528
Past hospitalization	1.551	.118	.130
BAI				.063
Ketamine use frequency	1.048	.251	.001^**
PANSS total score				0.044
Duration of ketamine dependence	.036	.100	.181
Past hospitalization	2.751	.162	.031^*
P Subscore				0.045
Average ketamine dose	−.104	−.164	.027^*
Past hospitalization	.578	.166	.026^*
G Subscore				0.045
Duration of ketamine dependence	.028	.136	.068
Past hospitalization	1.314	.133	.075

^*

P<0.05.

^**

P<0.001.